Vivalink Introduces New Adhesive for Wearable ECG to Enhance Ambulatory Cardiac Monitoring and Clinical Research

Improves p-wave signal detection up to 160%, helping clinicians identify atrial abnormalities to prevent future adverse cardiac events

• Vivalink's ECG patch and adhesive is pliable, water resistant, and comfortable for all day wear
• P-wave detection is a critical component of diagnosing cardiac arrhythmia
• Continual monitoring with Vivalink's multi-vital ECG patch improves the quality of data collected and eases patient burden

CAMPBELL, Calif., Sept. 9, 2025 /PRNewswire/ -- Vivalink, a leading provider of digital healthcare solutions, today announced the commercial release of its new wearable ECG sensor adhesive that improves the detection of p-waves during ambulatory cardiac monitoring. P-wave abnormalities are strong predictors of future adverse cardiac events, including atrial fibrillation, ischemic stroke, and even sudden cardiac death. As a newly introduced companion to Vivalink's rechargeable, re-usable multi-vital ECG patch, the adhesive is a critical enhancement to Vivalink's wearable monitors, supporting earlier intervention, improved patient outcomes, and high-quality data collection in clinical trials.

Key features of the upgraded adhesive include:

• Modified Lead 1 placement to enhance p-wave visibility
• Single use, seven day wear time with water resistance
• Contoured design for maximum flexibility of movement
• Optimized for both comfort and data integrity
• Validated for use in remote and in-person clinical trial settings

Worn vertically on the center chest above the sternum, the adhesive increases p-wave signal detection by up to 160%. P-waves, which represent the electrical activity of the heart's upper chambers, are important markers of atrial health. Subtle changes in their shape or size can be early indicators of atrial disease, making clear signal capture vital for clinical decision-making in arrhythmias and atrial fibrillation risk, and strengthens the reliability of trial data. The design of the adhesive leverages Vivalink's patented eSkin™ technology for unparalleled user comfort and flexibility. It is the latest member of the family of adhesives that can be attached to Vivalink's multi-vital ECG patch achieving world-leading patient wearing experience.

Vivalink's multi-vital ECG patch is a lightweight, wearable cardiac monitor built for continuous ECG monitoring in clinical care, remote patient monitoring and clinical research environments. Reusable and chargeable, the patch streams live ECG and vital signs such as heart rate, respiratory rate, and skin temperature while also storing data locally to prevent gaps in the event of a network disruption. With up to two weeks of use between charges and a comfortable design, the patch allows for long-term monitoring without disrupting patients' daily activities.

"Continual innovation in wearable monitoring technology is at the core of our mission," said Jiang Li, CEO of Vivalink. "By improving p-wave signal clarity, this new adhesive advances the accuracy and reliability of cardiac monitoring. The result is better support for clinicians in identifying arrhythmias early, while easing the burden on patients through comfortable, long-term use in ambulatory settings, hospital-at-home programs and clinical trials that demand accurate ECG data."

For more information about Vivalink's solutions, visit www.vivalink.com.

About Vivalink
Vivalink is a provider of digital healthcare solutions for remote patient monitoring in healthcare and clinical trials. By combining medical wearables, advanced algorithms, and clinical applications, we provide a more effective and accessible approach to patient care worldwide.

Media Contact
[email protected]

SOURCE Vivalink